Template:Bleeding: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
(21 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{| class="infobox bordered" style="width: | {| class="infobox bordered" style="width: 18%; text-align: left; font-size: 85%; background:AliceBlue" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
Line 7: | Line 7: | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
|- bgcolor="LightCoral" | |- bgcolor="LightCoral" | ||
! | ! | ||
Line 13: | Line 12: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
Line 19: | Line 17: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
Line 25: | Line 22: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
Line 31: | Line 27: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
Bleeding | : [[Bleeding Academic Research Consortium]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ | : [[TIMI bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ | : [[GUSTO bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ | : [[CURE bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ | : [[ACUITY HORIZONS bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ | : [[STEEPLE bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ | : [[PLATO bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
:[[ | : [[GRACE bleeding criteria]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
Line 97: | Line 72: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Line 103: | Line 77: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
Line 109: | Line 82: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Bleeding reversal of anticoagulation and antiplatelet in active bleed|Reversal of Anticoagulation and Antiplatelet in Active Bleed]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
Perioperative Bleeding | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative bleeding anemia management|Anemia Management]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative bleeding monitoring of coagulation status and platelet function|Coagulation Monitoring]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative bleeding coagulation management|Coagulation Management]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]] | ||
|- | :: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Antiplatelet Agents|Antiplatelet Agents]] | ||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Heparin|Heparin]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Fondaparinux|Fondaparinux]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Vitamin K Antagonists|Vitamin K Antagonists]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#New Oral Anticoagulants|New Oral Anticoagulants]] | |||
:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Comorbidities Involving Hemostatic Derangement|Comorbidities Involving Hemostatic Derangement]] | |||
|- | |||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
: [[ | : [[Bleeding perioperative bleeding management in specific surgeries|Specific Surgeries]] | ||
:: [[Bleeding perioperative bleeding management in specific surgeries#Cardiovascular Surgery|Cardiovascular Surgery]] | |||
:: [[Bleeding perioperative bleeding management in specific surgeries#Gynecological (Non-Pregnant) Bleeding|Gynecological Bleeding]] | |||
:: [[Bleeding perioperative bleeding management in specific surgeries#Obstetric Bleeding|Obstetric Bleeding]] | |||
:: [[Bleeding perioperative bleeding management in specific surgeries#Orthopedic Surgery and Neurosurgery|Orthopedic/Neurosurgery]] | |||
:: [[Bleeding perioperative bleeding management in specific surgeries#Visceral and Transplant Surgery|Visceral/Transplant Surgery]] | |||
:: [[Bleeding perioperative bleeding management in specific surgeries#Pediatric Surgery|Pediatric Surgery]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Bleeding | : [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders|Congenital Bleeding Disorders]] | ||
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#von Willebrand Disease|von Willebrand Disease]] | |||
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Platelet Defects|Platelet Defects]] | |||
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Hemophilia A and B|Hemophilia A and B]] | |||
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Factor VII Deficiency|Factor VII Deficiency]] | |||
:: [[Bleeding perioperative bleeding prevention and treatment in patients with congenital bleeding disorders#Rare Bleeding Disorders|Rare Bleeding Disorders]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " | ||
! | ! | ||
Line 165: | Line 144: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 171: | Line 149: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 177: | Line 154: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 183: | Line 159: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 189: | Line 164: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 195: | Line 169: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 201: | Line 174: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 212: | Line 184: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 218: | Line 189: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 224: | Line 194: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 230: | Line 199: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 236: | Line 204: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 242: | Line 209: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 248: | Line 214: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 254: | Line 219: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 260: | Line 224: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
Line 266: | Line 229: | ||
|- | |- | ||
! | ! | ||
|} | |} |
Latest revision as of 13:10, 25 April 2014
Bleeding Microchapters |
Treatment |
---|
Reversal of Anticoagulation and Antiplatelet in Active Bleed |
Perioperative Bleeding |
Bleeding On the Web |
American Roentgen Ray Society Images of Bleeding |